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Negative pressure for a short period of time
produces a cleavage plane in the epidermis of mice
(Levine et al., 1982), and reproducible,
noninflammatory vesicles with a viable epidermal
covering formed in the cleft (Kiistala, 1968;
Middleton, 1980) can be inoculated with murine
melanoma to obtain a 97% yield of tumours
(Levine et al., 1982). While comparing neoplastic
growth in the immunologically privileged hamster
cheek pouch with cutaneous implants, we developed
a simple and inexpensive technique of
simultaneously producing multiple vesicles suitable
for inoculation.
Four RC-20 reversed microliter pipette tips
(6mm i.d., Rainin Instrument Co., Woburn,
Massachusetts) were placed in a rectangular array
1.0cm from the center of a Lab-Tek specimen
container (Daly Hospital Supply Co., Lynnfield,
Massachusetts) (Figure 1). Connections were sealed
with epoxy glue. This suction chamber was
attached to a Weiss vacuum regulator (Cole-Parmer
Instrument Co., Chicago, Illinois) connected to wall
suction. Multiple suction chambers could be used in
parallel when joined with Y-connectors.
H2Tb pancreatic duct cell adenocarcinoma cells
(Townsend et al., 1982) from samples donated by
Dr C.M. Townsend, Jr., Galveston, Texas, were
grown in RPM1-1640 media supplemented with
10% foetal calf serum, penicillin 10OUml-1, and
streptomycin 100lgml-l at 37°C in 95% air and
5% CO2. The media was changed every 2-3 days,
and the cells were recultured when confluent, on
average every 4-6 days.
Male LVG Syrian golden hamsters (100g;
Charles River Breeding Laboratory, Wilmington,
Massachusetts) were fed Purina Rodent Laboratory
Chow and maintained under 12h light-dark cycles
beginning at 6.00 a.m.
Hamsters were randomly allocated to one of two
groups for tumour inoculation: intracutaneous
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Figure 1 Blister apparatus. The suction regulator is
attached to one suction chamber with four vesicle
forming prongs. Several chambers may be connected
in parallel.
(n= 5) and into the cheek pouch (n= 5). For the
intracutaneous inoculation, depilation of the back
followed anaesthesia with pentobarbitol
(80mgkg 1 i.p.). Suction was applied to the skin at
100mm Hg for 15min. Into each of four potential
spaces formed by the vacuum, 1.5 x 105 H2Tb cells
were injected in 50pl of basal media. For cheek
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pouch implantation the same inoculum was injected
simultaneously at two sites in each everted cheek
pouch of anaesthetized animals.
Tumours were periodically calibrated using the
formula V=4/3H-a2b/2, where a is the shortest
dimension and b is the longest dimension (Hibasami
& Ito, 1981).
The cost of the equipment described here for the
production of cutaneous vesicles is less than 10%
that of the commercially available Dermovac
(Instrumentarium, Helsinki, approx. $785). In
addition, the apparatus can be used on multiple
animals simultaneously and in a fraction of the
recommended time (5min vs. 2h).
An inoculum of only 2.5 x 105 cells produced
tumour nodules 100% ofthe time in the cheek pouch
and in the skin within 24h. Although growth
kinetics were similar in both groups during the first
12 days, at Day 16 the intracutaneous tumours
were 20% smaller than the cheek pouch ones
(Figure 2).
Necrosis was first seen at 16 days in 4/19 cheek
pouch tumours; by 21 days all cheek pouch
tumours had some evidence of necrosis. In this
group no correlation was found between the onset
of necrosis and size. No ulceration and no visible
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Figure 2 Volume of growing tumours in the
intracutaneous nodules (0) and in the cheek pouch
(0), days after inoculation. Data points are given
+s.e.
necrosis on sectioning were observed in the
intracutaneous tumours to 40 days after
inoculation.
Although intracutaneous tumours were
consistently spherical (Figure 3), there was no
uniformity of shape of the cheek pouch tumours.
The disparity in shapes of the cheek pouch tumours
became more prominent 48h after inoculation. In
Figure 3 Transplanted tumours. Four transplanted pancreatic tumours (arrows) growing on hamster back 8
days after inoculation.
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the intracutaneous model, 4/20 tumours (all 4 in the
same animal) involuted between 12-16 days. Only
one cheek pouch tumour disappeared; the rest of
the nodules continued to grow. Involuted tumours
were excluded from the final analysis.
There are several advantages of the
intracutaneous model: clear visualization and easy
accessibility of the tumour nodules, reproducible
sizes of identical shape, no necrosis at 40 days for
fast growing tumours, and no anaesthesia
requirement for the accurate measurement of
tumour size. The disadvantage of this method is
that it is not immunologically privileged as the
hamster cheek pouch or the anterior chamber of
the eye (Billingham & Silvera, 1971; Gimbrone et
al., 1974).
Intracutaneous inoculation of tumours seems to
be a simple, inexpensive, efficient and reproducible
system for growth of transplantable cells.
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